Abstract

Interleukin-1 (IL-1) plays a crucial role in numerous inflammatory diseases via action on its only known signaling IL-1 receptor type 1 (IL-1R1). To investigate the role of IL-1 signaling in selected cell types, we generated a new mouse strain in which exon 5 of the Il1r1 gene is flanked by loxP sites. Crossing of these mice with CD4-Cre transgenic mice resulted in IL-1R1 loss of function specifically in T cells. These mice, termed IL-1R1ΔT, displayed normal development under steady state conditions. Importantly, isolated CD4 positive T cells retained their capacity to differentiate toward Th1 or Th17 cell lineages in vitro, and strongly proliferated in cultures supplemented with either anti-CD3/CD28 or Concanavalin A, but, as predicted, were completely unresponsive to IL-1β administration. Furthermore, IL-1R1ΔT mice were protected from gut inflammation in the anti-CD3 treatment model, due to dramatically reduced frequencies and absolute numbers of IL-17A and interferon (IFN)-γ producing cells. Taken together, our data shows the necessity of intact IL-1 signaling for survival and expansion of CD4 T cells that were developed in an otherwise IL-1 sufficient environment.

Highlights

  • Interleukin-1 (IL-1) is a pro-inflammatory cytokine that plays a prominent role in inflammation and immunoregulation

  • IL-1 receptor antagonist competes with IL-1 for its signaling IL-1 receptor type 1 (IL-1R1)

  • Experiments using mice with a complete knock out of IL-1R1 helped in deciphering the role of IL-1 signaling especially in infection models and models of autoimmune diseases, those experiments had limitations when trying to evaluate the cell type specific contribution of IL-1 signaling in complex pathologies

Read more

Summary

Introduction

Interleukin-1 (IL-1) is a pro-inflammatory cytokine that plays a prominent role in inflammation and immunoregulation. Its importance was confirmed by a variety of drugs designed to neutralize IL-1 activity, that showed beneficial effects in clinical settings [1]. Despite the complex process of IL-1 maturation and secretion [1, 2], its biological activity is tightly controlled by numerous negative signaling regulators. IL-1 receptor antagonist competes with IL-1 for its signaling IL-1 receptor type 1 (IL-1R1). The soluble form of IL-1R1, PLOS ONE | DOI:10.1371/journal.pone.0161505. The soluble form of IL-1R1, PLOS ONE | DOI:10.1371/journal.pone.0161505 August 23, 2016

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.